Processa Pharmaceuticals, Inc. Common (PCSA) is a publicly traded Healthcare sector company. As of July 29, 2026, PCSA trades at $1.86 with a market cap of $7.17M and a P/E ratio of -0.27. PCSA moved -38.92% today. Year to date, PCSA is +5.90%; over the trailing twelve months it is -47.30%. Its 52-week range spans $1.67 to $37.50. Rallies surfaces PCSA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Processa Pharmaceuticals, Inc. Common (PCSA) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. PCSA moved -38.92% today.
| Metric | Value |
|---|---|
| Price | $1.86 |
| Market Cap | $7.17M |
| P/E Ratio | -0.27 |
| EPS | $-10.36 |
| Dividend Yield | 0.00% |
| 52-Week High | $37.50 |
| 52-Week Low | $1.67 |
| Volume | 8.47M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-13.56M |
| Gross Margin | 0.00% |
PCSA analyst coverage data. Average price target: $0.00.